newsfilter
← Latest News
GlobeNewswire·

Viracta Therapeutics to Host R&D Day on October 4, 2023

SAN DIEGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (NASDAQ:VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers that impact